SPIKE 1.0 is a genetically engineered version of Brucella melitensis that has been further modified to produce hydroxyindole — a naturally occurring microbial metabolite. Once injected, it homes to tumors and begins reshaping the tumor microenvironment (TME), reducing suppressive signals and enhancing immune recognition. This metabolic remodeling creates a more favorable landscape for the immune system to attack and eliminate cancer cells.